Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/25474
Başlık: Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles
Yazarlar: Lin, Hungyung
Sudha, Thangirala
Bharali, Dhruba Jyoti
Meng, Ran
Tang, Hengyuan
Davis, Faith B.
Stain, Steven Charles
Davis, Paul J.
Mousa, Shaker A.
Uludağ Üniversitesi/Veteriner Fakültesi/Fizyoloji Anabilim Dalı.
0000-0002-5600-8162
Yalçın, Murat
AAG-6956-2021
57192959734
Anahtar kelimeler: Oncology
Endocrinology & metabolism
Activated protein-kinase
Fibroblast-growth-factor
Thyroid-hormone
Integrin alpha-v-beta-3
Proangiogenic action
Surface receptor
Up-regulation
Glioma-cells
L-thyroxine
Resveratrol
Yayın Tarihi: Haz-2013
Yayıncı: Springer
Atıf: Yalçın, M. vd. (2013). "Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles". Hormones and Cancer, 4(3), 176-185.
Özet: Tetraiodothyroacetic acid (tetrac) and its nanoparticle formulation (Tetrac NP) act at an integrin cell surface receptor to inhibit tumor cell proliferation and tumor-related angiogenesis. Human pancreatic cancer cell (PANC-1 and MPanc96) xenografts were established in nude mice, and the effects of tetrac versus Tetrac NP on tumor growth and tumor angiogenesis were determined. The in vitro effects of tetrac and Tetrac NP were also determined by reverse transcription polymerase chain reaction or immunoblot on gene expression or gene products relevant to cell cycle arrest, apoptosis, or angiogenesis. Tetrac and Tetrac NP reduced both PANC-1 tumor mass by 45-55 % and PANC-1 tumor hemoglobin content, a marker of angiogenesis, by 50-60 % (*P < 0.05) in treated groups vs. controls by treatment day 15. Comparable results were obtained with tetrac and Tetrac NP in suppressing tumor growth and tumor angiogenesis in MPanc96 xenografts. In vitro studies showed that tetrac and Tetrac NP caused accumulation of pro-apoptotic protein BcLx-s. Tetrac NP was more effective than tetrac in increasing cellular abundance of mRNAs of pro-apoptotic p53 and p21 and anti-angiogenesis thrombospondin 1 protein in PANC-1 and MPanc96 cancer cell lines. Tetrac NP noticeably decreased expression of EGFR and of anti-apoptosis gene XIAP; tetrac did not affect EGFR and increased XIAP mRNA in both MPanc96 and PANC-1. In conclusion, tetrac or Tetrac NP effectively inhibited human pancreatic xenograft growth and tumor angiogenesis via a plasma membrane receptor that downstream modulated cellular abundance of proteins or mRNAs relevant to apoptosis and angiogenesis.
URI: https://doi.org/10.1007/s12672-013-0137-y
https://link.springer.com/content/pdf/10.1007/s12672-013-0137-y.pdf
http://hdl.handle.net/11452/25474
ISSN: 1868-8497
1868-8500
Koleksiyonlarda Görünür:Scopus
Web of Science

Bu öğenin dosyaları:
Dosya Açıklama BoyutBiçim 
Yalçın_vd_2013.pdf531.57 kBAdobe PDFKüçük resim
Göster/Aç


Bu öğe kapsamında lisanslı Creative Commons License Creative Commons